10.09.19
Hugh Davis, chief business officer at Frontage Laboratories, talks about the CRO's range of services and its expansion into biologics and early development capabilities.
Related Breaking News
-
Stevanato Group to Demo Robotic Inspection Unit at INTERPHEX
To present modular assembly solutions and recent after-sales expansion.10.20.21
-
Marchesini Group to Showcase Three New Machines at INTERPHEX
A monobloc machine for counting and capping, a Turbo Emulsifier and AVI machine for inspection of liquid, lyophilized or powder products in vials or syringes.10.20.21
-
Breaking News
Jones Healthcare Group Earns Silver-Medal Ranking from EcoVadis
Puts Jones in the top 20% best companies rated by EcoVadis in 2021.10.19.21
-
Breaking News | Drug Development | Promotions & Moves
Boyds Adds Two Product Development Experts to Its Team
Welcomes Diane Shattock Ph.D., as director of product development & Ian Hollingsworth M.Sc. as associate director of product development.10.19.21
-
Financial Reports
J&J Pharmaceutical Sales up 14% in the Quarter
COVID-19 Vaccine contributes $502 million in sales.10.19.21
-
Breaking News | Industry News
Aptar CSP Awarded $19M U.S. Govt. Contract for Activ-Film Technology
To support expanded domestic production capacity for Activ-Film technology used to protect and ensure COVID-19 test kit integrity and accuracy.10.19.21
-
Breaking News | Industry News | Injectables
West to Unveil DeltaCube and New NovaGuard SA at INTERPHEX
DeltaCube Platform aims to aid decisions for container closure systems and NovaGuard SA Pro safety system expanded for ISO standard 0.5mL glass syringes.10.19.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Logistics | Supply Chain
Autolomous, Vineti Form Cell and Gene Therapy Supply Chain Pact
To integrate Autolomous’ critical manufacturing management systems with Vineti’s Personalized Therapy Management platform to create a seamless delivery pathway.10.19.21
-
Breaking News | Industry News
Phillips-Medisize Increases Global Mfg. Capacity
Expands production facilities and R&D centers in Poland, China and the U.S.10.19.21
-
Collaborations & Alliances
Antios Therapeutics, Assembly Biosciences Enter Clinical Collaboration
Will evaluate a triple combination treatment in patients with chronic hepatitis B virus (HBV) infection.10.19.21
-
Fill/Finish | Reader Showcase
Syntegon Introduces Solutions for Lab-Scale and Small Batch Filling
The new GKF 60 capsule filling machine and the Versynta Flexible Filling Platform (FFP) make their first live appearance at INTERPHEX.10.19.21
-
Reader Showcase | Serialization
WIPOTEC-OCS to Demonstrate Serialization & Aggregation Units at INTERPHEX
TQS-SP Serialization Unit for applying track & trace data and TQS-CP Aggregation Unit provides semi-automatic aggregation of manually repacked folding boxes.10.19.21
-
Breaking News | Drug Development
Landmark Bio Appoints Two New Leaders to Executive Team
Welcomes Gregg Nyberg as chief technology officer and Michael Covington as chief quality and regulatory officer.10.19.21
-
Fill/Finish | Reader Showcase
TurboFil to Showcase Latest Syringe Fillers at INTERPHEX
To showcase the SimpliFil Syringe Filling & Assembly System and new benchtop syringe filling machine TipFil Syringe Filler.10.19.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Trials & Filings
Valneva COVID Vax Meets Co-primary Endpoints in Phase III Trial
Inactivated, adjuvanted VLA2001 demonstrates superiority against AZD1222 in terms of neutralization antibodies.10.18.21
